Pretransplant Serum Creatinine in Peritoneal Dialysis Patients Predicts Graft Outcomes

IF 3.4 Q1 UROLOGY & NEPHROLOGY
Faisal Jarrar , Karthik K. Tennankore , Ngan N. Lam , David A. Clark , Bryce A. Kiberd , Amanda J. Vinson
{"title":"Pretransplant Serum Creatinine in Peritoneal Dialysis Patients Predicts Graft Outcomes","authors":"Faisal Jarrar ,&nbsp;Karthik K. Tennankore ,&nbsp;Ngan N. Lam ,&nbsp;David A. Clark ,&nbsp;Bryce A. Kiberd ,&nbsp;Amanda J. Vinson","doi":"10.1016/j.xkme.2025.101056","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><div>Although peritoneal dialysis (PD) as a pretransplant dialysis modality is associated with favorable outcomes after kidney transplant, it is unknown if pretransplant serum creatinine (Scr) level is associated with subsequent graft outcomes in candidates managed with PD. Our objective was to examine the association between Scr at the time of transplant and short-term and long-term outcomes posttransplant.</div></div><div><h3>Study Design</h3><div>Retrospective cohort study.</div></div><div><h3>Setting &amp; Participants</h3><div>A total of 20,166 adult (≥18 years of age) patients who were receiving PD at the time of a first living or deceased donor kidney transplant in the United States between 2000 and 2017, identified using the Scientific Registry of Transplant Recipients database.</div></div><div><h3>Exposures</h3><div>Primary exposure was final Scr level before transplant, categorized as<!--> <!-->&lt;5, 5-8, 8-12, and<!--> <!-->&gt;12<!--> <!-->mg/dL. Sensitivity analyses for patient subgroups included recipient age (≥50 vs<!--> <!-->&lt;50 years) and dialysis vintage (≥3 vs<!--> <!-->&lt;3 years) at transplant.</div></div><div><h3>Outcomes</h3><div>The primary outcome was death-censored graft loss (DCGL). Secondary outcomes included all-cause graft loss and delayed graft function (DGF).</div></div><div><h3>Results</h3><div>Pretransplant Scr was significantly associated with DCGL (adjusted HR, 1.17; 95% CI, 1.02-1.34 for Scr<!--> <!-->&gt;12<!--> <!-->mg/dL [reference<!--> <!-->&lt;5<!--> <!-->mg/dL]) and DGF (adjusted OR, 2.71; 95% CI, 2.26-3.26 for Scr<!--> <!-->&gt;12<!--> <!-->mg/dL [reference<!--> <!-->&lt;5<!--> <!-->mg/dL]). There was no association with all-cause graft loss. The risk of DCGL and DGF associated with high pretransplant Scr was higher for those who were older (≥50 years) and those with longer dialysis vintage (≥3 years).</div></div><div><h3>Limitations</h3><div>No access to potential predictors of pretransplant Scr including residual kidney function, dialysis adequacy and adherence; exact timing of Scr values pretransplant was unknown.</div></div><div><h3>Conclusions</h3><div>To our knowledge, this is the first study to explore the association between pretransplant Scr level in PD patients and graft outcomes after kidney transplantation. The reason for this increased risk is unclear but may reflect reduced residual kidney function, among other factors.</div></div><div><h3>Plain-Language Summary</h3><div>Kidney transplantation is a life-saving procedure and is associated with improved survival for people living with kidney failure. However, kidney transplants may fail during the lifetime of transplant recipients. Identifying treatable factors that contribute to kidney transplant failure before transplantation is important. Many of these factors relate to dialysis before transplantation. Therefore, our study examined whether creatinine level before transplantation in peritoneal dialysis patients influences transplant survival. Our study of more than 20,000 patients from the United States found that peritoneal dialysis patients with elevated pretransplant creatinine levels have a significantly higher risk of transplant loss. This finding is important because it identifies high creatinine as a predictor and potentially treatable factor that contributes to kidney transplant failure.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":"7 9","pages":"Article 101056"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059525000925","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale & Objective

Although peritoneal dialysis (PD) as a pretransplant dialysis modality is associated with favorable outcomes after kidney transplant, it is unknown if pretransplant serum creatinine (Scr) level is associated with subsequent graft outcomes in candidates managed with PD. Our objective was to examine the association between Scr at the time of transplant and short-term and long-term outcomes posttransplant.

Study Design

Retrospective cohort study.

Setting & Participants

A total of 20,166 adult (≥18 years of age) patients who were receiving PD at the time of a first living or deceased donor kidney transplant in the United States between 2000 and 2017, identified using the Scientific Registry of Transplant Recipients database.

Exposures

Primary exposure was final Scr level before transplant, categorized as <5, 5-8, 8-12, and >12 mg/dL. Sensitivity analyses for patient subgroups included recipient age (≥50 vs <50 years) and dialysis vintage (≥3 vs <3 years) at transplant.

Outcomes

The primary outcome was death-censored graft loss (DCGL). Secondary outcomes included all-cause graft loss and delayed graft function (DGF).

Results

Pretransplant Scr was significantly associated with DCGL (adjusted HR, 1.17; 95% CI, 1.02-1.34 for Scr >12 mg/dL [reference <5 mg/dL]) and DGF (adjusted OR, 2.71; 95% CI, 2.26-3.26 for Scr >12 mg/dL [reference <5 mg/dL]). There was no association with all-cause graft loss. The risk of DCGL and DGF associated with high pretransplant Scr was higher for those who were older (≥50 years) and those with longer dialysis vintage (≥3 years).

Limitations

No access to potential predictors of pretransplant Scr including residual kidney function, dialysis adequacy and adherence; exact timing of Scr values pretransplant was unknown.

Conclusions

To our knowledge, this is the first study to explore the association between pretransplant Scr level in PD patients and graft outcomes after kidney transplantation. The reason for this increased risk is unclear but may reflect reduced residual kidney function, among other factors.

Plain-Language Summary

Kidney transplantation is a life-saving procedure and is associated with improved survival for people living with kidney failure. However, kidney transplants may fail during the lifetime of transplant recipients. Identifying treatable factors that contribute to kidney transplant failure before transplantation is important. Many of these factors relate to dialysis before transplantation. Therefore, our study examined whether creatinine level before transplantation in peritoneal dialysis patients influences transplant survival. Our study of more than 20,000 patients from the United States found that peritoneal dialysis patients with elevated pretransplant creatinine levels have a significantly higher risk of transplant loss. This finding is important because it identifies high creatinine as a predictor and potentially treatable factor that contributes to kidney transplant failure.

Abstract Image

Abstract Image

Abstract Image

腹膜透析患者移植前血清肌酐预测移植预后。
理由和目的:尽管腹膜透析(PD)作为一种移植前透析方式与肾移植后的良好预后相关,但移植前血清肌酐(Scr)水平是否与PD患者随后的移植结果相关尚不清楚。我们的目的是研究移植时Scr与移植后短期和长期预后之间的关系。研究设计:回顾性队列研究。环境和参与者:在2000年至2017年期间,在美国接受首次活体或已故供体肾移植时接受PD的20,166名成人(≥18岁)患者,使用移植接受者科学注册数据库确定。暴露:主要暴露为移植前的最终Scr水平,分类为12mg /dL。患者亚组的敏感性分析包括受体年龄(≥50岁)与结局:主要结局是死亡审查的移植物损失(DCGL)。次要结局包括全因移植物损失和移植物功能延迟(DGF)。结果:移植前Scr与DCGL显著相关(校正HR, 1.17;[参考文献12 mg/dL]限制:无法获得移植前Scr的潜在预测因子,包括残余肾功能、透析充分性和依从性;移植前Scr值的确切时间尚不清楚。结论:据我们所知,这是第一个探讨PD患者移植前Scr水平与肾移植后移植结果之间关系的研究。这种风险增加的原因尚不清楚,但可能反映了残余肾功能的降低,以及其他因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信